Board of Directors

According to Saniona's Article of Associations, the Board of Directors shall consist of not less than three and not more than eight members. Currently, the Board of Directors consist of six members including the chairman.

 

 

J. Donald deBethizy (born 1950)

Chairman of the Board since 2018

Education: Ph.D. and M.Sc. in Toxicology from Utah State University and a B.Sc. in Biology from the University of Maryland

Other assignments: Chairman of the Board of Saniona A/S, President of White City Consulting ApS, Chairman of the Boards of Albumedix A/S and Noxxon Pharma NV (ALNOX.EN Paris), Board member of argenx N.V. (ARGX BR), Newron Pharmaceuticals SpA (NWRN.SWX) and Proterris, Inc.

Previous assignments: President and CEO of Santaris Pharma A/S. Executive Chairman of Contera Pharma ApS. Member of the Board of Asceneuron SA, Biosource Inc., Enbiotix Inc., LigoCyte Pharmaceuticals Inc., Rigontec GmbH, Serendex Pharmaceuticals A/S, Targacept Inc. and Albumedix A/S. He was also the Co-Founder and CEO of Targacept, Inc., a NASDAQ-listed U.S. biotechnology company from 1997-2012

No. of shares: 0

No. of warrants: 217,625

Non-affiliated to the management, the company and major shareholders

 

Jørgen Drejer (born 1955)

Member of the board, CSO and Co-Founder of the company. CEO from 2014-2020.

Education: PhD in neurobiology

Other assignments: Member of the board and CSO of Saniona A/S. Board member of 2CureX AB and 2CureX A/S

Previous assignments: CEO of Saniona. Executive Vice President, Board member, Research Director and co-founder of NeuroSearch A/S. Member of the Board of Directors of Atonomics A/S, NSGene A/S, Origio A/S, Zgene A/S, Aktieselskabet af 20. November 2003, Delta Reader A/S, Azign Bioscience A/S, Force Technology, Ellegaard Göttingen Minipigs ApS, and Monta Biosciences A/S

No. of shares: 2,344,711

No. of warrants: 161,704 of series TO 2 and TO 3

Affiliated to the management, the company and major shareholders

 

 

Anna Ljung (born 1980)

Member of the board and chairman of the Audit Committee since 2018

Education: M.Sc. in Economics and Business Administration from the Stockholm School of Economics

Other assignments: Member of the board of Saniona A/S. CEO of Moberg Pharma AB.

Previous assignments: CFO of Moberg Pharma AB, CFO of Athera Biotechnologies AB, CFO of Lipopeptide AB and independent consultant in the field of technology licensing

No. of shares: 0

No. of warrants: 8,000

Non-affiliated to the management, the company and major shareholders

 

Carl Johan Sundberg (born 1958)

Member of the Board since 2015

Education: MD

Other assignments: Member of the Board of Saniona A/S. Professor at the Department of Physiology & Pharmacology at Karolinska Institutet, Stockholm, Sweden. Board member of Cobra Biologics Holding AB, Arne Ljungqvist Anti-doping Foundation AB and Medkay Konsulting AB, partner in Medkay Konsulting HB. Head of the Department of Learning, Informatics, Management and Ethics at Karolinska Institutet, member of the International Olympic Committee´s Medical Commission and an elected member of the Royal Swedish Academy of Engineering Sciences (IVA)

Previous assignments: Board member of Alfta Rehab Holding AB, KI Management AB, KI Management Partners AB, Karolinska Development AB and NsGene A/S

No. of shares: 0

No. of warrants: 8,000

Non-affiliated to the management, the company and major shareholders

 

Edward C. Saltzman (born 1955)

Member of the Board since 2019

Education: Degree from New York University

Other assignments: Executive Chairman of Cello Health BioConsulting, previously Defined Health, after having led the sale of Defined Health to Cello Health in 2017. Serves as a Venture Advisor to the Israel Biotech Fund and is a board member of Vidac Pharmaceuticals Ltd.

No. of shares: 0

No. of warrants: 4,000

Non-affiliated to the management, the company and major shareholders